Okay, let's tackle this question. The patient has a liver cyst caused by Echinococcus granulosus and refused surgery, so they're on high-dose albendazole for three months. The question is about monitoring for toxicity.

First, I need to recall what albendazole is used for. It's an antiparasitic, specifically for echinococcosis. Now, the main toxicities of albendazole. I remember that it can affect the liver, because it's a benzimidazole derivative. Benzimidazoles inhibit microtubule formation, which is why they're effective against parasites. But in humans, that can lead to some side effects.

Wait, the patient is already having a liver cyst, so their liver might be compromised. Using a drug that's metabolized in the liver and can cause hepatotoxicity could be a problem. So, monitoring liver enzymes like ALT, AST, and maybe bilirubin would be important. Also, albendazole can cause bone marrow suppression, so checking CBC for leukopenia or thrombocytopenia is another aspect. But the question is about toxicity they should monitor for during treatment.

Another point: albendazole is a teratogen, so pregnancy should be avoided, but that's not an option here. The main toxicities in the context of long-term high-dose use are hepatotoxicity and bone marrow suppression. So the monitoring would include liver function tests and blood counts.

Looking at the options, if the correct answer is related to liver enzymes, then the other options might be other systems. Let's say the options are A: Renal function, B: Cardiac enzymes, C: Liver function tests, D: Thyroid function. Then the correct answer would be C. The incorrect options are not typically monitored for albendazole toxicity. Renal issues aren't a main concern, cardiac enzymes like troponin aren't standard, and thyroid isn't related here.

So the core concept is that albendazole's toxicity includes liver and bone marrow effects, so monitoring LFTs and CBC is key. The clinical pearl is to remember that with high-dose and prolonged use, LFTs are a must.

**Core Concept**
Albendazole, a benzimidazole antiparasitic, is used for cystic echinococcosis. It inhibits microtubule polymerization in parasites, impairing their cellular function. However, it can cause dose-dependent toxicity, particularly affecting the liver and bone marrow due to similar mechanisms in human cells.

**Why the Correct Answer is Right**
Albendazole is metabolized in the liver and can induce hepatotoxicity, manifesting as elevated liver enzymes (ALT/AST), bilirubin, or jaundice. Prolonged high-dose therapy (e.g., 3 months) increases this risk, necessitating regular monitoring of **liver function tests (LFTs)**. Patients with pre-existing liver disease (e.g., hepatic cysts) are at higher risk.

**Why Each Wrong Option is Incorrect**
**Option A:** Renal function tests are not a primary concern with albendazole; nephrotoxicity is rare.
**Option B:** Cardiac enzymes are irrelevant here. Albendazole does not cause myocardial damage.
**Option D:** Thyroid function

✓ Correct Answer: C. Liver